Talha Badar, Associate Professor at Mayo Clinic Comprehensive Cancer Center, shared on X:
“CAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission.
Title: CAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission
Authors: Ibrahim Aldoss, Lior Goldberg, Jianying Zhang, Andrew Artz, Mary C. Clark, Min Guan, Ruby Espinosa, Thiruvaimozhi Abimannan, Jiaqi Wu, Bryan Garcia, Eric R. Haas, Khyatiben V. Pathak, Brooke Lovell, Patrick Pirrotte, Vaibhav Agrawal, Neguine Sanani, Stephanie Kasten, Dileshni Tilakawardane, Jamie R. Wagner, Jinny Paul, Haoyue Shan, Samer Khaled, Lihua E. Budde, Paul Koller, Anthony S. Stein, Vinod Pullarkat, Amandeep Salhotra, Ahmed Aribi, Guido Marcucci, Xiuli Wang, Stephen J. Forman
Provocative phase 1 data for CAR T as definitive consolidation in B-ALL CR1: 18 adults treated with CD19 CAR T had no DLTs, grade ≥2 CRS, or ICANS, with 18-mo EFS 84% and OS 100%. Biology also differed strikingly from R/R ALL.”
Other articles about CAR T-cell therapy on OncoDaily.